Search

Search Constraints

You searched for: Author/Creator Takekuma, Munetaka

Search Results

1. 28/#262 Dose-dense, weekly paclitaxel and carboplatin with or without bevacizumab, in metastatic or recurrent cervical carcinoma (final analysis of JCOG1311). (4th December 2022)

3. A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082). (4th March 2021)

4. A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082). Issue 4 (4th March 2021)

5. A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082). Issue 4 (April 2021)

6. Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study. Issue 9 (September 2022)

7. Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element. (September 2018)

9. Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy. (3rd September 2015)

10. Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826. Issue 11 (15th September 2022)